Reduced levels of frataxin in FRDA patients are associated with defects of iron–sulphur (Fe–S) cluster biosynthesis [7], mitochondrial iron accumulation in the heart, spinal cord and dentate nucleus of the cerebellum [8] and increased susceptibility to oxidative stress [9]. The gene discussed is FXN; the disease is Friedreich ataxia.